🔴 Boston Scientific is trading 11.46% down today after cutting full-year EPS guidance

Boston Scientific is trading at $39.90, down 11.46%, after cutting full-year adjusted EPS guidance.

• On October 28, 2026, Q3 adjusted EPS was $0.73, below the $0.80–$0.82 outlook; sales growth was 1.5%.
• Full-year adjusted EPS guidance fell to $3.16–$3.18 from $3.28–$3.32; Q4 sales are expected to decline 1%–3%.
• Management tied results and outlook to an August cybersecurity incident disrupting operations; reporting linked the share drop to the guidance cut. The reaction was company-specific, not broad-market weakness.